Adaptive Biotechnologies Corporation

Halal Rating :
See Details
Last Price $3.10 Last updated:
Market Cap $532.0m
7D Change 0.65%
1 Year Change 0.65%

Company Overview

  • Commercial Services
  • Miscellaneous Commercial Services
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing
Exchange NASDAQ
Next Earnings Date Feb. 14, 2024

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is headquartered in Seattle, Washington.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
March 31, 2024 $38.88m $147.64m $4.22m $2.99m 10.86% 2.03%
Dec. 31, 2023 $42.77m $188.3m $4.61m $3.01m 10.79% 1.60%
Sept. 30, 2023 $34.27m $133.52m $4.28m $3.65m 12.50% 2.74%

Company Impact

Help us evaluate Adaptive Biotechnologies Corporation's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates